Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors

by NASDAQ Market News November 25, 2019

NASDAQ Market News
Click here to email author

AB Science provides the summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis

Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens

Ads